In-vitro ADME

 

Drug disposition property optimization

  • Physico-chemical properties optimization
    • Log D
    • Permeability (Caco-2, MDR1-MDCK, PAMPA)
    • Solubility
  • In vitro drug metabolism
    • Plasma protein binding
    • Brain tissue binding assay
    • Metabolic stability
    • CYP inhibition and Induction
    • Drug transporters
  • Drug – Drug Interaction (DDI) prediction: Devise plans to assess mechanistic based clinical drug-drug interaction risk potential of a drug candidate with respect to
    • Direct inhibition, mechanistic based inhibition and induction
    • Drug transporter
  • Metabolite identification